BSE filing, NSE: FEDFINA. Summary written from the filing by ALFA Finder's alert engine.
Fedbank Financial Services Ltd: key numbers
- Share price
- ₹148.70
- Market cap
- ₹5,580 Cr
- Revenue (annual)
- ₹2,224 Cr
- Net profit (annual)
- ₹343.6 Cr
- P/E (TTM)
- 12.9×Sector 19.7×
- Promoter holding
- 60.64%-0.03% QoQ
- FII holding
- 9.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fedbank Financial Services Ltd
All →Fedbank Financial Services Employee Stock Options
Fedbank Financial granted 1,65,000 ESOS-2024 stock options to eligible employees at Rs 155.10 each. Vesting occurs between one and four years from grant.
- Execution
- Vesting not earlier than 1 year and not later than 4 years from grant; exercisable within 3 years of vesting
Fedbank Financial Services Earnings Call Transcript: Key Takeaways
Fedfina delivered its strongest profitability quarter with ROE hitting 17% and PAT growing 63% YoY. The company is successfully transitioning from high-cost direct assignment reliance to core income growth.
- Call
- Guides 25% growth
Fedbank Financial Services Employee Stock Options
Fedbank Financial Services Limited has allotted shares under its ESOP scheme. The allotment increases the company's paid-up share capital by approximately Rs. 0.08 Crore.
- Value
- ₹0.08 Cr
Fedbank Financial Services Employee Stock Options
Fedbank Financial Services Limited allotted 84,890 equity shares following the exercise of vested stock options under its ESOS 2018 scheme.
Fedbank Financial Services Investor Presentation: Key Takeaways
Fedbank Financial Services reported strong Q2 FY27 results with AUM growing 36.6% YoY to ₹22,035 Cr. Strategy focuses on collateralized MSME lending across gold and mortgage products.
Fedbank Financial Services Results Update
Fedbank Financial Services reported a 63.1% YoY increase in Net Profit to ₹130.8 Crore for Q2 FY27. Assets Under Management grew 36.6% to ₹22,035 Crore.
- Value
- ₹130.8 Cr
- total branches
- 831.0 branches
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.